StockTipsArenaBeta

BUY Alkem Laboratories Limited — Macquarie

BUYAlkem Laboratories Limited
Alkem Laboratories share price target & all analyst calls

byMacquarieHorizon: NA (inferred 1 year)7 Oct 2026via Zee Business (Live)

Entry₹5,297Inferred
Target₹6,000
Total upside +13.27%
Stop lossNot given
CMP₹5,249.53h ago
Active-0.90%+14.30%upside left 12 mo left
Follow Macquarie for new callsGet alertsWatch ALKEM for new buy/sell callsGet alertsSee 7 other Long-term calls on ALKEMSee 105 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 8 Oct, 7:53 pm IST
15 supporting7 neutral4 opposing
Supports the BUY call (15)

Alkem Laboratories Limited has launched NeuCeno (cenobamate) for treating partial-onset seizures in adult patients.

BSE · Company Update·16 Sept · 3w ago

(opens in new tab)

3 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·28 Aug · 1mo ago

Neutral / worth noting (7)

Alkem Laboratories to hold EGM on Aug 17 for amalgamation with Adroit Biomed

NewsGoogle News·6 Oct · 2d ago

(opens in new tab)
Weighs against the BUY call (4)

Long-term trend bearish — 200-day average falling over the past quarter

Technicals · trend·7 Oct · yesterday

1 other SEBI-registered advisor has an active long-term SELL call on this stock

Advisor consensus · same horizon·14 Aug · 2mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Alkem Laboratories

All analyst calls on Alkem Laboratories

More from Macquarie

Every call and its outcome